BR9201848A - Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos - Google Patents

Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos

Info

Publication number: BR9201848A
Authority: BR; Brazil
Prior art keywords: virus; vaccines; vaccine; particuals; prophylaxis
Prior art date: 1991-05-17

Application number

BR929201848A

Other languages

English (en)

Inventor

John Sidney Oxford

Original Assignee

Retroscreen Ltd Companhia Brit

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-17

Filing date

1992-05-15

Publication date

1993-01-05

1992-05-15 Application filed by Retroscreen Ltd Companhia Brit filed Critical Retroscreen Ltd Companhia Brit

1993-01-05 Publication of BR9201848A publication Critical patent/BR9201848A/pt

Links

241000700605 Viruses Species 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 3
229960005486 vaccine Drugs 0.000 title abstract 3
208000036142 Viral infection Diseases 0.000 title 1
238000011321 prophylaxis Methods 0.000 title 1
238000011282 treatment Methods 0.000 title 1
230000009385 viral infection Effects 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 2
230000000415 inactivating effect Effects 0.000 abstract 2
229940124718 AIDS vaccine Drugs 0.000 abstract 1
239000003431 cross linking reagent Substances 0.000 abstract 1
239000003599 detergent Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
230000003019 stabilising effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16061—Methods of inactivation or attenuation
- C12N2760/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Hematology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Oncology (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Telephone Function (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

BR929201848A 1991-05-17 1992-05-15 Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos BR9201848A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919110808A GB9110808D0 (en)	1991-05-17	1991-05-17	Aids vaccine and method for its production

Publications (1)

Publication Number	Publication Date
BR9201848A true BR9201848A (pt)	1993-01-05

Family

ID=10695252

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR929201848A BR9201848A (pt)	1991-05-17	1992-05-15	Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos

Country Status (16)

Country	Link
US (1)	US5698432A (pt)
EP (1)	EP0514199B1 (pt)
JP (1)	JPH05328967A (pt)
KR (1)	KR0149182B1 (pt)
AT (1)	ATE172642T1 (pt)
AU (1)	AU652447B2 (pt)
BR (1)	BR9201848A (pt)
CA (1)	CA2068817A1 (pt)
DE (1)	DE69227400T2 (pt)
ES (1)	ES2127203T3 (pt)
GB (1)	GB9110808D0 (pt)
IE (1)	IE921556A1 (pt)
IN (1)	IN174080B (pt)
NZ (1)	NZ242780A (pt)
SG (1)	SG49763A1 (pt)
ZA (1)	ZA923607B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5525027A (en) *	1991-05-28	1996-06-11	Kabushiki Kaisha Toshiba	Working robot
AUPN030794A0 (en)	1994-12-22	1995-01-27	Aruba International Pty Ltd	Discontinuous plasma or serum delipidation
DE19520216C2 (de) *	1995-06-01	1997-04-10	Frey Rainer H	Vakzine zur Prophylaxe und Therapie von AIDS, und Verfahren zur Herstellung
US20040053208A1 (en) *	1995-08-29	2004-03-18	V. I. TECHNOLOGIES, Inc.	Methods to selectively inactivate parasites in biological compositions
US6093564A (en) *	1997-10-03	2000-07-25	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
US6352695B1 (en) *	1997-10-03	2002-03-05	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
US6617100B2 (en)	1998-09-25	2003-09-09	V.I. Technologies, Inc.	Solid phase quenching systems
US6403359B1 (en)	1998-09-25	2002-06-11	V. I. TECHNOLOGIES, Inc.	Solid phase quenching systems
DE19916085A1 (de) *	1998-10-28	2000-05-04	Sonntag Hans Guenther	Verfahren zur Herstellung eines antiviralen Mittels
US6649170B1 (en) *	1999-05-12	2003-11-18	Statens Serum Institut	Adjuvant combinations for immunization composition and vaccines
ATE384786T1 (de) *	1999-12-20	2008-02-15	Agricultural Research Council	Verfahren zur inaktivierung von mikroorganismen
US7407662B2 (en) *	2000-06-29	2008-08-05	Lipid Sciences, Inc.	Modified viral particles with immunogenic properties and reduced lipid content
US20090017069A1 (en)	2000-06-29	2009-01-15	Lipid Sciences, Inc.	SARS Vaccine Compositions and Methods of Making and Using Them
US7407663B2 (en) *	2000-06-29	2008-08-05	Lipid Sciences, Inc.	Modified immunodeficiency virus particles
AUPQ846900A0 (en) *	2000-06-29	2000-07-27	Aruba International Pty Ltd	A vaccine
US7439052B2 (en)	2000-06-29	2008-10-21	Lipid Sciences	Method of making modified immunodeficiency virus particles
US20060060520A1 (en)	2001-06-25	2006-03-23	Bomberger David C	Systems and methods using a solvent for the removal of lipids from fluids
AU2002322284A1 (en) *	2001-06-25	2003-01-08	Lipid Sciences, Inc.	Systems and methods using multiple solvents for the removal of lipids from fluids
US6991727B2 (en)	2001-06-25	2006-01-31	Lipid Sciences, Inc.	Hollow fiber contactor systems for removal of lipids from fluids
DE10144906B4 (de) *	2001-09-12	2013-11-28	Novartis Vaccines And Diagnostics Gmbh	Verfahren zur großtechnischen Herstellung von Impfstoffen
WO2003048366A1 (en) *	2001-12-07	2003-06-12	Postech Foundation	Sivmac239 immunogenic plasmids and aids dna vaccine containing the same
US7393826B2 (en)	2003-07-03	2008-07-01	Lipid Sciences, Inc.	Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
JP2007527387A (ja)	2003-07-03	2007-09-27	リピッドサイエンシーズ，インコーポレイテッド	脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置
US8497112B2 (en) *	2007-08-28	2013-07-30	Baxter International Inc.	Method for producing viral vaccines
WO2011138229A1 (en) *	2010-05-03	2011-11-10	Glaxosmithkline Biologicals S.A.	Novel method
US9370562B2 (en) *	2012-06-01	2016-06-21	Boehringer Ingelheim Vetmedica Gmbh	Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
WO2013185052A1 (en)	2012-06-08	2013-12-12	Aduro Biotech	Compostions and methods for cancer immunotherapy
MX361680B (es)	2012-12-13	2018-12-13	Aduro Biotech Inc	Composiciones que comprenden dinucleótidos de purina cíclicos que tienen estereoquímicas definidas y métodos para su preparación y uso.
EP4398254A2 (en)	2013-04-29	2024-07-10	Memorial Sloan Kettering Cancer Center	Compositions and methods for altering second messenger signaling
EP2992000B1 (en)	2013-05-03	2020-07-08	The Regents of The University of California	Cyclic di-nucleotide induction of type i interferon
PL2996473T3 (pl)	2013-05-18	2020-06-01	Aduro Biotech, Inc.	Kompozycje i sposoby aktywacji sygnałowania zależnego od „stymulatora genu interferonu”
US9549944B2 (en)	2013-05-18	2017-01-24	Aduro Biotech, Inc.	Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
EP3027227A4 (en)	2013-07-31	2018-05-23	Memorial Sloan Kettering Cancer Center	Sting crystals and modulators
JP5865942B2 (ja)	2014-04-16	2016-02-17	三菱電機株式会社	内燃機関のシリンダ吸入空気量推定装置および推定方法
WO2016145102A1 (en)	2015-03-10	2016-09-15	Aduro Biotech, Inc.	Compositions and methods for activating "stimulator of interferon gene" -dependent signalling
US11098077B2 (en)	2016-07-05	2021-08-24	Chinook Therapeutics, Inc.	Locked nucleic acid cyclic dinucleotide compounds and uses thereof
US11027052B2 (en)	2017-11-22	2021-06-08	HDL Therapuetics, Inc.	Systems and methods for priming fluid circuits of a plasma processing system
UY37695A (es)	2017-04-28	2018-11-30	Novartis Ag	Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
JP2021509894A (ja)	2017-12-28	2021-04-08	エイチディーエルセラピューティクスインコーポレイテッドＨｄｌＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	ヒト血漿から抽出されたｐｒｅ−β高密度リポタンパク質を保存および投与するための方法
EP3743107A1 (en)	2018-01-22	2020-12-02	The United States of America, as represented by the Secretary, Department of Health and Human Services	Broadly protective inactivated influenza virus vaccine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617457A1 (de) *	1966-12-16	1972-04-20	Erba Carlo Spa	Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte
US4036952A (en) *	1973-02-24	1977-07-19	Bayer Aktiengesellschaft	Ethyleneimine inactivated microorganisms
DE2321951C2 (de) *	1973-05-02	1975-05-07	Behringwerke Ag, 3550 Marburg	Verfahren zur Herstellung einer Diphtherie-Vaccine
US4086134A (en) *	1973-09-18	1978-04-25	University Of Glasgow	Method for preparation of vaccine against feline leukemia
GB1503388A (en) *	1975-07-01	1978-03-08	Inverni Della Beffa Spa	Pharmaceutically active complexes and pharmaceutical compositions containing them
US4452734A (en) *	1980-02-11	1984-06-05	Merck & Co., Inc.	Herpes subunit vaccine
US4481189A (en) *	1982-04-14	1984-11-06	New York Blood Center Inc.	Process for preparing sterilized plasma and plasma derivatives
US4645666A (en) *	1982-06-08	1987-02-24	The Regents Of The University Of California	Vaccine for bluetongue disease employing platinum compounds
US4530831A (en) *	1982-11-02	1985-07-23	Akzo N.V.	Infectious Bursal Disease vaccine
US4806350A (en) *	1986-04-18	1989-02-21	Norden Laboratories, Inc.	Vaccine formulation
EP0250128A3 (en) *	1986-06-18	1988-06-08	American Registry of Pathology	Novel virus isolated from patients with aids
DE3707987A1 (de) *	1987-03-12	1988-09-22	Behringwerke Ag	Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole
GB8906794D0 (en) *	1989-03-23	1989-05-10	Carroll Noel	Preparation of vaccines

1991
- 1991-05-17 GB GB919110808A patent/GB9110808D0/en active Pending
1992
- 1992-05-15 CA CA002068817A patent/CA2068817A1/en not_active Abandoned
- 1992-05-15 AU AU16340/92A patent/AU652447B2/en not_active Ceased
- 1992-05-15 IN IN294MA1992 patent/IN174080B/en unknown
- 1992-05-15 DE DE69227400T patent/DE69227400T2/de not_active Expired - Fee Related
- 1992-05-15 AT AT92304422T patent/ATE172642T1/de not_active IP Right Cessation
- 1992-05-15 ES ES92304422T patent/ES2127203T3/es not_active Expired - Lifetime
- 1992-05-15 EP EP92304422A patent/EP0514199B1/en not_active Expired - Lifetime
- 1992-05-15 BR BR929201848A patent/BR9201848A/pt not_active Application Discontinuation
- 1992-05-15 SG SG1996004956A patent/SG49763A1/en unknown
- 1992-05-18 JP JP4168187A patent/JPH05328967A/ja active Pending
- 1992-05-18 NZ NZ24278092A patent/NZ242780A/en not_active IP Right Cessation
- 1992-05-18 ZA ZA923607A patent/ZA923607B/xx unknown
- 1992-05-18 KR KR1019920008346A patent/KR0149182B1/ko not_active IP Right Cessation
- 1992-07-01 IE IE155692A patent/IE921556A1/en not_active IP Right Cessation
1996
- 1996-10-11 US US08/729,135 patent/US5698432A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IE921556A1 (en)	1992-11-18
JPH05328967A (ja)	1993-12-14
DE69227400D1 (de)	1998-12-03
SG49763A1 (en)	1998-06-15
ZA923607B (en)	1993-02-24
EP0514199A2 (en)	1992-11-19
ATE172642T1 (de)	1998-11-15
CA2068817A1 (en)	1992-11-18
NZ242780A (en)	1994-07-26
US5698432A (en)	1997-12-16
AU652447B2 (en)	1994-08-25
AU1634092A (en)	1992-12-17
IN174080B (pt)	1994-09-10
EP0514199B1 (en)	1998-10-28
KR920021162A (ko)	1992-12-18
GB9110808D0 (en)	1991-07-10
EP0514199A3 (en)	1993-11-10
DE69227400T2 (de)	1999-07-01
KR0149182B1 (ko)	1998-10-15
ES2127203T3 (es)	1999-04-16

Legal Events

Date	Code	Title
1995-01-24	EE	Request for examination
1999-02-17	EG	Technical examination (opinion): publication of technical examination (opinion)
1999-08-24	FC	Decision: refusal
2000-03-08	FC	Decision: refusal

Publication	Publication Date	Title
BR9201848A (pt)	1993-01-05	Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos
PT97754A (pt)	1992-04-30	Processo para a preparacao de composicoes farmaceuticas contendo pelo menos um agente inibidor da poli-(adp-ribose)-polimerase nomeadamente, uma amida aromatica, para o tratamento de infeccoes provocadas por virus
BR9712138A (pt)	2000-01-18	Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição.
BR9812232A (pt)	2000-07-18	Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
BR9712592A (pt)	1999-12-21	Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
ATE544466T1 (de)	2012-02-15	Verwendung von cpg oligonukleotide zur behandlung von hepatitis c virus infektion
ATE319483T1 (de)	2006-03-15	Verfahren und zusammensetzungen zur selektiven modikation von nukleinsäuren
ES2107609T3 (es)	1997-12-01	Polipeptidos sinteticos como inhibidores de vih-1.
BR9913406A (pt)	2002-01-29	Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
ATE364624T1 (de)	2007-07-15	Multisystemisches kümmerwuchssyndrom durch viren in schweine
DE69536039D1 (de)	2010-02-11	Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
ATE335831T1 (de)	2006-09-15	Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
ES2113348T3 (es)	1998-05-01	Composiciones de vacunas estabilizadas.
BR0316244A (pt)	2005-10-04	Vacina de polinucleotìdeo, métodos de prevenção ou de tratamento de uma infecção por hcv em um mamìfero e de vacinação de um indivìduo, e, uso de uma vacina de polinucleotìdeo
DK0507179T3 (da)	2000-05-29	Equine herpesvira (EHV), der indeholder fremmed
BR9707400A (pt)	2000-01-04	Vacinas contra produto do gene 63 de vìrus varicella zoster.
ES2062990T3 (es)	1995-01-01	Vacunas, que contienen la proteina f del virus del sida.
WO1999057284A3 (en)	1999-12-29	Attenuated influenza viruses
BR0108442A (pt)	2003-03-25	Mutantes-ehv gm-negativos
EP0247873A3 (en)	1988-10-19	Bacteriocins and compositions thereof in anti-viral treatment
ATE100318T1 (de)	1994-02-15	Verwendung von chinolyl- und isochinolyloxazol-2- onen zur herstellung eines arzneimittels zur verhinderung der ansteckungsfaehigkeit von mit glykoproteinen umhuellten viren.
ATE189604T1 (de)	2000-02-15	Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
FI893346A0 (fi)	1989-07-10	Icke-reverterande rna-virus.
DE69021879D1 (de)	1995-09-28	Verfahren zur herstellung von impfstoffen gegen rna-virus.
RU93005232A (ru)	1996-09-27	Вирусы, применение вирусов, вакцина, способ получения вируса